South Carolina General Assembly
125th Session, 2023-2024

Bill 4617


Indicates Matter Stricken
Indicates New Matter


(Text matches printed bills. Document has been reformatted to meet World Wide Web specifications.)

Committee Report

May 01, 2024

 

H. 4617

 

Introduced by Reps. Hixon, Davis, M. M. Smith, Bannister, Pope, Wooten, Haddon, Brewer, Burns, Thayer, Kirby, Oremus, Hager, Hyde, Sessions, Carter, McDaniel, Magnuson, Hayes, W. Newton, Bauer, Trantham, J. L. Johnson, Henegan, Guffey, Chapman, Leber, Kilmartin, Robbins, Felder, Jefferson, Caskey, Ligon and Vaughan

 

S. Printed 05/01/24--S.

Read the first time January 16, 2024

 

________

 

The committee on Senate Judiciary

To whom was referred a Bill (H. 4617) to amend the South Carolina Code of Laws by amending Section 44-53-230, relating to Schedule III controlled substances, so as to add xylazine as a Schedule III controlled, etc., respectfully

Report:

That they have duly and carefully considered the same, and recommend that the same do pass with amendment:

 

    Amend the bill, as and if amended, SECTION 1, by striking Section 44-53-230(c)13 and inserting:

       13. Xylazine.

Amend the bill further, by adding an appropriately numbered SECTION to read:

SECTION X. Chapter 53, Title 44 of the S.C. Code is amended by adding:

 

    Section 44-53-373. Nothing in this article applies to veterinarians in connection with the practice of their profession and the legitimate use of xylazine within the veterinary practice, including:

    (A) the distribution or possession of xylazine by a licensed veterinarian for use in legitimate veterinary practice;

    (B) the possession of xylazine pursuant to a valid prescription from a licensed veterinarian; or

    (C) the possession of xylazine in an injectable form for use in nonhuman species.

 

Renumber sections to conform.

Amend title to conform.

 

LUKE RANKIN for Committee.

 

_______


 

 

 

 

 

 

 

 

A bill

 

TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY AmendING SECTION 44-53-230, relating to schedule iii controlled substances, SO AS TO ADD XYLAZINE as a schedule III controlled substance, WITH EXCEPTIONS; AND BY ADDING SECTION 44-53-372 SO AS TO PROHIBIT THE PRODUCTION, MANUFACTURE, DISTRIBUTION, OR POSSESSION OF XYLAZINE, WITH EXCEPTIONS, AND TO ESTABLISH ASSOCIATED CRIMINAL PENALTIES.

 

Be it enacted by the General Assembly of the State of South Carolina:

 

SECTION 1.  Section 44-53-230(c) of the S.C. Code is amended by adding:

 

        13. Xylazine, except when used in any of the following manners:

           (A) the distribution or possession of xylazine by a licensed veterinarian for use in legitimate veterinary practice;

           (B) the possession of xylazine pursuant to a valid prescription from a licensed veterinarian; or

           (C) the possession of xylazine in an injectable form for use in a nonhuman species.

 

SECTION 2.  Article 3, Chapter 53, Title 44 of the S.C. Code is amended by adding:

 

    Section 44-53-372. (A)(1) It is unlawful for any person to knowingly or intentionally produce, manufacture, distribute, or possess with intent to produce, manufacture, or distribute xylazine for a use other than a nonhuman use.

       (2) A person who violates the provisions of this subsection is guilty of a felony and, upon conviction, must be imprisoned not more than ten years or fined not more than fifteen thousand dollars, or both.

    (B)(1) It is unlawful for any person to knowingly or intentionally possess xylazine.

       (2) A person who violates the provisions of this subsection is guilty of a misdemeanor and, upon conviction, must be imprisoned not more than one hundred eighty days or fined not more than five hundred dollars, or both.

    (C) The provisions of this section do not apply to any of the following:

       (1) the production, manufacturing, distribution, or possession of xylazine for use in legitimate veterinary practice;

       (2) the production, manufacturing, distribution, or possession of a xylazine bulk chemical for pharmaceutical compounding by a licensed pharmacist or veterinarian for use in a nonhuman species;       (3) the possession of xylazine pursuant to a valid prescription from a licensed veterinarian for use in a nonhuman species; or

       (4) the possession of xylazine in an injectable form for use in a nonhuman species.

    (D) For purposes of this section, "xylazine" means xylazine and any salt, sulfate, isomer, homologue, analogue, or other preparation of xylazine, and any salt, isomer, compound, derivative, precursor, homologue, analogue, or other preparation thereof that is substantially chemically equivalent or identical to xylazine.

 

SECTION 3.  This act takes effect upon approval by the Governor.

----XX----

This web page was last updated on May 01, 2024 at 08:22 PM